BBOT
Price:
$11.54
Market Cap:
$923.07M
BridgeBio Oncology Therapeutics is a clinical-stage biopharmaceutical company developing next-generation small molecule therapeutics targeting RAS and PI3Kα malignancies, which are prevalent oncogenes in human tumors. Initially formed as a subsidiary of BridgeBio Pharma, it focuses on precision oncology with a pipeline that includes BBO-8520, BBO-10203, and BBO-11818 programs targeting KRAS and PI3K pathways. The company recently went public through a business combination with Helix Acquisition Corp. II, raising approximately $450 million to advance clinical development. The CEO is Dr. Eli Wallace, and the CSO is Dr. Pedro Beltran.
Industry
Biotechnology
IPO Date
2025-08-12
Stock Exchange
NASDAQ
Ticker
BBOT
According to BridgeBio Oncology Therapeutics Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of BridgeBio Oncology Therapeutics Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), BBOT's Dividend Yield was at its highest in in the December 2022 quarter at 0%. The Dividend Yield was at its lowest in in the December 2022 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of BridgeBio Oncology Therapeutics Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
| Year | Dividend Yield | Change |
|---|---|---|
| 2024 | 0% | 0% |
| 2023 | 0% | 0% |
| 2022 | 0% | 0% |
The current Dividend Yield of BridgeBio Oncology Therapeutics Inc. (BBOT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
BridgeBio Oncology Therapeutics Inc.’s Dividend Yield is less than Mind Medicine (MindMed) Inc. (0%), less than UroGen Pharma Ltd. (0%), less than Nurix Therapeutics, Inc. (0%), less than Xencor, Inc. (0%), less than Kodiak Sciences Inc. (0%), less than AnaptysBio, Inc. (0%), less than Phathom Pharmaceuticals, Inc. (0%), less than Oculis Holding AG (0%), less than Tango Therapeutics, Inc. (0%), less than Septerna, Inc. (0%),
| Company | Dividend Yield | Market cap |
|---|---|---|
| 0% | $939.13M | |
| 0% | $1.14B | |
| 0% | $1.39B | |
| 0% | $1.30B | |
| 0% | $1.31B | |
| 0% | $1.20B | |
| 0% | $1.05B | |
| 0% | $1.03B | |
| 0% | $1.09B | |
| 0% | $1.17B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BridgeBio Oncology Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BridgeBio Oncology Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is BridgeBio Oncology Therapeutics Inc.'s Dividend Yield?
How is the Dividend Yield calculated for BridgeBio Oncology Therapeutics Inc. (BBOT)?
What is the highest Dividend Yield for BridgeBio Oncology Therapeutics Inc. (BBOT)?
What is the 3-year average Dividend Yield for BridgeBio Oncology Therapeutics Inc. (BBOT)?
What is the 5-year average Dividend Yield for BridgeBio Oncology Therapeutics Inc. (BBOT)?
How does the current Dividend Yield for BridgeBio Oncology Therapeutics Inc. (BBOT) compare to its historical average?